filing a PMA is the goal, not approval . . . then they can call it the FDA's fault . . . epigenomics had no business filing theirs, but they did . . . this was MNKD's 3rd attempt . . . the story here is if the right to publicly trade gets maintained, or did green and charter just want equipment . . . the bread crumbs still point to saving the shell . . . you're getting to far ahead of the story . . .
News 
Market Data 
Discover 
